Review Article

Published in:
Volume 3 / Year 2014 / Issue 4

Safety assessment of biosimilars in Europe: a regulatory perspective

Author(s): ,
Page: 180-3

Abstract: Clinical safety is important during the development of a biosimilar. This paper provides an overview of the main aspects related to the safety assessment of biosimilars. The European Medicines… Read More »

Go Back Print